Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Argus Health
Julphar
Federal Trade Commission
Cipla
Chubb
Healthtrust
Fish and Richardson
Covington

Generated: February 23, 2018

DrugPatentWatch Database Preview

ELOCON Drug Profile

« Back to Dashboard

When do Elocon patents expire, and what generic alternatives are available?

Elocon is a drug marketed by Merck Sharp Dohme and is included in three NDAs.

The generic ingredient in ELOCON is mometasone furoate. There are twenty-nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
Drug patent expirations by year for ELOCON
Pharmacology for ELOCON
Medical Subject Heading (MeSH) Categories for ELOCON

US Patents and Regulatory Information for ELOCON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck Sharp Dohme ELOCON mometasone furoate CREAM;TOPICAL 019625-001 May 6, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Merck Sharp Dohme ELOCON mometasone furoate OINTMENT;TOPICAL 019543-001 Apr 30, 1987 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Merck Sharp Dohme ELOCON mometasone furoate CREAM;TOPICAL 019625-002 Apr 19, 2013 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Merck Sharp Dohme ELOCON mometasone furoate LOTION;TOPICAL 019796-001 Mar 30, 1989 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ELOCON

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme ELOCON mometasone furoate CREAM;TOPICAL 019625-001 May 6, 1987 ➤ Sign Up ➤ Sign Up
Merck Sharp Dohme ELOCON mometasone furoate LOTION;TOPICAL 019796-001 Mar 30, 1989 ➤ Sign Up ➤ Sign Up
Merck Sharp Dohme ELOCON mometasone furoate OINTMENT;TOPICAL 019543-001 Apr 30, 1987 ➤ Sign Up ➤ Sign Up
Merck Sharp Dohme ELOCON mometasone furoate CREAM;TOPICAL 019625-001 May 6, 1987 ➤ Sign Up ➤ Sign Up
Merck Sharp Dohme ELOCON mometasone furoate LOTION;TOPICAL 019796-001 Mar 30, 1989 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ELOCON
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Topical Solution (Lotion) 0.10% ➤ Subscribe 6/10/2004

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Cerilliant
Federal Trade Commission
AstraZeneca
Cantor Fitzgerald
Daiichi Sankyo
Deloitte
Chinese Patent Office
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot